glp-1 news today 2025 november ISPOR 2025: Exploring reasons for GLP-1 discontinuation GLP-1 Receptor Agonist Market Growth
Description
Both can produce nausea
Tell your healthcare provider if you have extreme tiredness, stomach pain, dark urine, or yellowing of the skin or whites of the eyes
Although more research is required to fully understand the mechanisms behind these effects, the current studies provide substantial evidence for its use in mitigating metabolic disorders
Heckmann notes that broader wellness trends are pulling aesthetics along with them
